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BioSentinel
The BioSentinel mission was selected in 
2013 as one of three secondary payloads 
to fly on the Space Launch System’s first 
Exploration Mission (EM-1) planned for 
launch in December 2017. The primary 
objective of BioSentinel is to develop a 
biosensor using a simple model organism to 
detect, measure, and correlate the impact 
of space radiation to living organisms over 
long durations beyond Low Earth Orbit 
(LEO). While progress identifying and 
characterizing biological radiation effects 
using Earth-based facilities has been 
significant, no terrestrial source duplicates 
the unique space radiation environment.
The BioSentinel biosensor uses the budding 
yeast S. cerevisiae to detect and measure 
double strand breaks (DSBs) that occur 
in response to ambient space radiation. 
DSBs are deleterious DNA lesions that are 
generated by exposure to highly energetic 
particles in the deep-space radiation 
spectrum and that are often repaired 
without errors by the cell. The biosensor 
consists of specifically engineered yeast 
strains and nutrient selection strategies that 
ensure that only cells that have repaired 
DSBs will grow in specialized media. 
Therefore, culture growth and metabolic 
activity of yeast cells directly indicate 
a successful DSB-and-repair event. 
In the BioSentinel payload, yeast cells 
are stored dried in microfluidic cards 
inside a 6-Unit (6U) spacecraft measuring 
approximately 14.4 inches long, 8.9 inches 
wide, and 3.9 inches tall. It weighs about 30 
pounds. At launch, BioSentinel resides within 
the second stage on the launch vehicle 
from which it is deployed to a lunar fly-by 
trajectory and into a heliocentric orbit where 
its distance to the sun is slightly closer than 
Earth’s, varying between 0.98 to 0.92 times 
Earth’s distance to the sun. After completing 
the lunar fly-by and spacecraft checkout, 
the science mission phase begins with the 
wetting of the first set of cell-containing wells 
with specialized media. The microfluidic 
cards carry three yeast strains: wild type 
(similar to yeast strains found in nature), 
rad52 mutant (defective in DSB repair), and 
the DSB biosensor strain. Each set of wells 
is expected to be in its active mode for 
2 – 4 weeks following hydration; multiple 
sets of wells will be activated at different 
time points over the 18-month mission. One 
reserve set of wells will be activated in the 
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occurrence of a Solar Particle Event (SPE). Payload 
science data and spacecraft telemetry will be stored 
on board and then downloaded to the ground.
Growth and metabolic activity of the yeast cells will be 
measured using a 3-color LED detection system and 
the metabolic indicator dye Alamar Blue. Biological 
measurements will be compared to data provided by 
onboard physical radiation sensors and dosimeters, and 
to Earth-based experiments using relevant energetic 
particle types, energies, and doses. Additionally, three 
identical BioSentinel payloads will be developed – 
one for the International Space Station (ISS), where 
there is similar microgravity but a comparatively 
low-radiation environment, one for use as a delayed-
synchronous ground control at Earth gravity and also 
with a low radiation environment, and one ground 
payload that will be used at Brookhaven National 
Laboratory in New York for radiation testing. Thus the 
BioSentinel payload will help calibrate the biological 
effects of radiation in deep space to analogous 
measurements conducted on Earth and on the ISS.
BioSentinel will conduct the first study of biological 
response to space radiation outside LEO in over 40 
years. BioSentinel will address strategic knowledge 
gaps related to the biological effects of space radiation 
and will provide an adaptable platform to perform 
human-relevant measurements in multiple space 
environments in the future. Yeast is the ideal organism 
for this mission because of its spaceflight heritage, 
it is highly capable of repairing DSBs, and it can be 
stored in stasis for a long period of time. Moreover, the 
DSB repair mechanisms in yeast are well studied and 
highly similar to those in human cells. BioSentinel’s 
results will be critical for improving interpretation of the 
effects of space radiation exposure, and for reducing 
the risk associated with long-term human exploration.
The BioSentinel mission is funded by the Advanced 
Exploration Systems program within the Human 
Exploration and Operations Mission Directorate at 
NASA Headquarters. Partner organizations include 
NASA Ames Research Center, NASA Johnson Space 
Center, Loma Linda University Medical Center, 
and the University of Saskatchewan, Canada.
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